Unused categories
Jump to navigation
Jump to search
The following category pages exist, although no other page or category makes use of them.
Showing below up to 32 results in range #1 to #32.
View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)
- Anti-CD20 cellular therapy
- Anti-CD3 antibodies
- Anti-Factor IXa antibodies
- Anti-Factor Xa antibodies
- Anti-GPRC5D antibodies
- Anti-HGFR antibodies
- Biliary tract cancer regimens
- Bladder cancer medications (historic)
- Bladder cancer medications (investigational)
- CNS carcinoma medications
- Chronic myeloid leukemia medications (investigational)
- Cold agglutinin disease medications (investigational)
- Colorectal cancer medications (investigational)
- Desmoid tumor medications (investigational)
- Esophageal cancer medications (investigational)
- Esophageal squamous cell carcinoma medications (investigational)
- FDA withdrawn in 2021
- Germ cell tumor regimens
- Germ cell tumors medications
- HGF inhibitors
- Hematology fellowship programs
- Hepatobiliary cancer medications
- LH-RH agonist
- Medullary thyroid cancer medications
- Melanoma medications (investigational)
- Nasopharyngeal carcinoma medications (investigational)
- Oncology fellowship programs
- PGF inhibitors
- Small bowel carcinoma medications
- Supportive regimens
- Surgery
- Thyroid cancer medications (investigational)